Pedophilia: Is it genetic?

Gawker published a piece on the neurological problems which might result in pedophilia, and naturally a lot of shock and disgust was triggered. The piece is titled Born This Way: Sympathy and Science for Those Who Want to Have Sex with Children. This isn’t something you want to click through to lightly. So fair warning. The neurobiological material did pique my interest:

“There was nothing significant in the frontal lobes or temporal lobes,” says Cantor. “It turned out the differences weren’t in the grey matter. The differences were in the white matter.”

“The white matter” is the shorthand term for groupings of myelinated axons and glial cells that transmit signals throughout the gray matter that composes the cerebrum. Think of the gray matter like the houses on a specific electricity grid and the white matter like the cabling connecting those houses to the grid.

View the original article here: Pedophilia: Is it genetic?

Free market view of California Prop 37

When Californians go to the polls this November, one of the ballot initiatives they will vote on will be the California Right to Know Genetically Engineered Food Act, a proposed law that would require that foods containing genetically modified organisms (GMOs) be specially labeled. This move for mandatory labeling is just the latest development in the ongoing controversy over the safety of genetically modified (GM) foods.

Proponents of the technology argue that creating GM plants and animals for human consumption is essentially no different from the selective breeding that farmers have carried out for millennia, which resulted in accumulated genetic changes over time. But the methods used to create today’s genetically modified organisms allow for more rapid and dramatic changes. Modern GMOs are often created using recombinant DNA techniques in which an organism’s genes are directly altered, often by inserting DNA fragments from other organisms. This approach offers much greater precision than selective breeding, removing the requirement of several generations of breeding for a particular trait to become widespread in a population. It also allows for the direct addition to an organism of novel traits that do not occur naturally in the species.

View the original article here: Free market view of California Prop 37

Gene to gene interactions important to trait variance

Gaining more insight into predicting how genes affect physical or behavioral traits by charting the genotype-phenotype map holds promise to speed discoveries in personalized medicine. But figuring out exactly how genes interact has left parts of the map invisible.

In a paper published in Proceedings of the National Academy of Sciences, North Carolina State University genetics researchers reveal some of the hidden portions of the map, showing that complicated networks of gene-gene interactions in fruit flies greatly influence the variance in quantitative traits, or characteristics that are influenced by multiple genes – like sensitivity to alcohol or aggression.

View the original article here: Gene to gene interactions important to trait variance

Shortness: Environmental factors can alter genetics

Depression doesn’t just hurt–it stunts growth, according to a new study published in the journal Pediatrics.

Mothers who suffer from depression the first year of their child’s life are more likely to have shorter kids, based on findings by researchers at the Johns Hopkins Bloomberg School of Public Health.

Pamela Surkin, an associate professor at the university, led a team of researchers in analyzing data of over 6,000 mothers and babies through the course of four years. They discovered moms with moderate to severe depression nine months after their children were born, were 50 percent more likely to have shorter kids by the time they turned five.

Surkin believes the side effects of postpartum depression are at the root of her results.

“We hypothesize that the main link between maternal postpartum symptoms of depression and child height is through care-giving behaviors, perhaps by means of feeding practices or through these mothers’ reduced abilities to get help for their sick children when they are sick,” Pamela J. Surkan, the study’s lead researcher and an assistant professor at the Johns Hopkins Bloomberg School of Public Health, tells Yahoo! Shine.

View the original article here: Shortness: Environmental factors can alter genetics

West Australian government dismisses as scaremongering call to abandon GM wheat trial

SCIENTISTS from three countries are warning a CSIRO-led push to make Australia the first nation in the world to introduce genetically modified wheat crops could pose a significant health threat to humans and other animals.

The wheat crop in question, believed to be undergoing field trials in Western Australia, NSW and the ACT, is genetically modified to produce a grain with a lower glycaemic index, which is touted as healthier because the carbohydrates are more gradually absorbed. This in turn delays the return of hunger pangs, and helps reduce sudden swings in blood sugar, which is particularly good for diabetics.

View the original article here: West Australian government dismisses as scaremongering call to abandon GM wheat trial

Kenya divided on use of GM crops

The Kenya Agricultural Research Institute (KARI), a semi-autonomous government research institution, recently announced that after years of trials, genetically modified drought-resistant maize seeds will be available to Kenyan farmers within the next five years. Trial GM drought-resistant cotton crops are already growing in Kidoko, 240 miles southeast of Nairobi.

Researchers and lobbyists argue that in a country so frequently stricken by food shortages, scientific advancements can put food into hungry bellies. Drought-resistant seeds and vitamin-enriched crops could be agricultural game changers, they say.

But serious concerns about viability, corporate dependency and health effects linger — even while leading research firms and NGOs do their best to smooth them over.

Highest European court confirms GM crop rights

On Sept. 6, the European Court of Justice clarified the legal requirements for the cultivation of genetically-modified (GM) crops in the Member States of the European Union. The Court confirmed that additional national authorization procedures, introduced on top of the existing approval process conducted by the European authorities (European Food Safety Authority) to be unlawful. It also declared that coexistence measures are not mandatory to grow GM plants.

“The cultivation of genetically modified organisms such as the MON 810 maize varieties cannot be made subject to a national authorization procedure when the use and marketing of those varieties are authorized” said the Court of Justice. The relevant EU legislation “does not entitle a Member State to prohibit in a general manner the cultivation on its territory of such genetically modified organisms pending the adoption of coexistence measures to avoid the unintended presence of genetically modified organisms in other crops” added the European institution.

View the original article here: Highest European court confirms GM crop rights

Are biorefineries the future?

I caught an interesting report last week by John Licata, founder of Blue Phoenix Inc. via CME Group in a PDF titled “Biorefineries May be New Greenfield”. Licata starts out explaining that following three decades of refinery contraction in the U.S. (the last one built in 1976), American consumers are now feeling this lack of refinery capacity in the way of higher gasoline prices. We are down to 144 operable U.S. refineries, the fewest since 1949. He warns that because of more stringent govenment fuel requirements coming, and older refineries incapable of breaking down crude to more eco-friendly gasoline, we will continue to see pump prices head upwards.

View the original article here: Are biorefineries the future?

Fumbled DNA tests mean peril for breast-cancer patients

Debbie McCarron was prepared to get both of her breasts taken off if a blood test in December 2006 revealed she carried a gene that vastly increases the risk of breast cancer. Having survived the disease five years earlier, she didn’t want to risk getting it again.

To her relief, her oncologist told her the test, done by Myriad Genetics Inc. (MYGN), had come back negative, “just like I knew it would,” McCarron recalls her doctor saying.

He was wrong. The results, in fact, were positive. McCarron didn’t learn this, though, until July 2009, more than two years later, when a genetic counselor reviewed the test following McCarron’s surgery to remove a new malignant breast tumor. Since then, her oncologist, Haresh Jhangiani, told Bloomberg he isn’t clear about what happened.

“I don’t think she was positive. Was she positive?” the doctor said. “I would not tell her it was negative if the test was positive, there must be something more to it.”

View the original article here: Fumbled DNA tests mean peril for breast-cancer patients

Will personalized medicine challenge or reify categories of race and ethnicity?

In the last 5 years, medical geneticists have been conducting studies to examine possible links between DNA and disease on an unprecedented scale, using newly developed DNA genotyping and sequencing technologies to quickly search the genome. These techniques have also allowed researchers interested in human genetic variation to begin to catalogue the range of genetic similarities and differences that exist across individuals from around the world, through initiatives such as the International Haplotype Mapping Project [1]. These studies of human genetic variation promise to produce new kinds of information about our DNA, but they have also raised ethical questions.

Early results from genome-wide studies of possible links between DNA and various medical conditions are being used by various actors to develop what they call “personalized medicine,” the effort to tailor and individualize diagnoses and treatments for use during routine medical care. The promises of personalized medicine are built on the idea that each individual’s genome is unique. They are also built on the idea that genetic variation among individuals will help explain differential susceptibilities to disease and why some patients respond better to some treatments than others. To this end, researchers have focused on characterizing genetic differences between individuals and groups.

View the original article here: Will personalized medicine challenge or reify categories of race and ethnicity?

Myriad Genetics patent dispute: Genes are patentable, and that’s OK, says author

The recent Association for Molecular Pathology v. Myriad Geneticspatent dispute involving two genes for breast and ovarian cancer, BRCA 1 and BRCA 2, has been widely followed by the media over the last several years. According to some the case highlights a potentially devastating future where humans have no control over their very own genetic code. Even worse, they say, patenting sequences of human DNA limits academic research and delays inevitable benefits to society. While there is certainly cause for concern I believe the recent attacks on Myriad Genetics, Inc. (NASDAQ: MYGN) have been a bit overdone.

View the original article here: Myriad Genetics patent dispute: Genes are patentable, and that’s OK, says author

Genetic blueprint of unborn baby in sight

genetic blueprint
Sequencing the whole genome of a fetus could provide a medical early warning on a previously unknown scale – but it also brings dilemmas. If you could peer into your baby’s medical future, what traits would you most want assurance about?
Additional Resources:

Europe debates use of modified olive fly

As Spain revs up its annual campaign against one of its olive crop’s biggest enemies – the olive fly – another campaign is underway in Europe against allowing a genetically modified (GM) ‘sterile’ fly to be used as a chemical-free alternative.

Every year, aerial spraying and ground control including pheromone baits are used in Spain to reduce infestation but the stakes are particularly high now with the country deeper in financial crisis, and drought, frosts and other factors expected to at least halve output next season, which officially starts in October.

And in world olive oil capital Andalusia the regional government is reported to have withdrawn subsidies for olive fly control at the same time as farmers face a national sales tax hike.

Olimerca reports that in the Baena Denomination of Origin, olive growers will bear the up to €170,000 ($214,000) cost of aerial spraying 60,000 hectares.

Meanwhile, a European Food Safety Authority panel has just ended public consultation on a document that could pave the way for use of GM olive flies. This was one of the possible future applications of GM insects listed in its “Guidance on the environmental risk assessment of genetically modified animals.”

GeneWatch UK says such a move would be a “massive gamble with our food supplies and the environment” and “billions of GM insect eggs and caterpillars would be left in vegetables and fruit”, including olives.

View the original article here: Europe debates use of modified olive fly

The genetics behind Venus, the mysterious two-faced cat

A cat named Venus is one of the most famous felines on the planet. The three-year-old torty has her own Facebook page and has collected more than a million views on YouTube, in addition to making appearances on the Today Show and in other news venues. The reason behind Venus’ fame? Her striking two-face markings: half black-with-yellow eye, half orange-with-blue-eye.

National Geographic investigates the possible genetic anomalies that contribute to Venus’ unique look. Cat geneticist Leslie Lyons of the University of California, Davis, told NatGeo that she’s never seen a kitty quite like Venus. “She is extremely, extremely rare,” she said.

Venus is not necessarily a chimera, or an animal whose cells contain two sets of DNA caused when two embryos fuse together during development. But Lyons said to find out for sure whether or not Venus is a chimera, she’d need to perform genetic testing.

If the cat is no chimera, what would explain her striking pattern? “Absolute luck,” Lyons told NatGeo. For example, the black coloration could have randomly activated in all of the cells on one side of her adorable kitty face, while cells coding for orange coloration kicked in on the other side. The two patches then met in the middle as she developed in the womb.

View the original article here: The genetics behind Venus, the mysterious two-faced cat

Brahman genetics provide relief for drought-stricken herds

Two summers of dire drought conditions in a vast majority of the U.S. has made drought relief a hot topic among the nation’s cattlemen. The importance of selecting cattle that fit the environment is more apparent now than ever before, especially considering the extremely hot and dry conditions, limited forage and high feed prices that have driven cattlemen to disperse their herds. Yet, even with the undesirable weather pattern, herd dispersal can be avoided. In fact, it has been avoided. Many Brahman and Brahman F-1 breeders have taken advantage of the American Brahman’s drought tolerance to keep their business afloat.

Nationwide, the value of “eared” genetics, especially in cow herds, is taking on a whole new meaning. As the No. 1 beef breed for heat tolerance, efficiency and hybrid vigor, American Brahman genetics are proven to increase drought resistance in their progeny. Brahman F-1s are even more adaptable, heat resistant and efficient than their non-Brahman parent.

View the original article here: Brahman genetics provide relief for drought-stricken herds

UC Davis professors warn of high cost of Prop 37

The No on Proposition 37 campaign emailed Thursday to tout a new study by UC Davis professors. It concludes that the proposition on the November ballot to require the labeling of genetically engineered foods would cost the food industry more than a billion dollars and lead to higher food costs from consumers.

The study doesn’t read like the usual, carefully couched work of academics. It’s a spitfire of a report that boldly starts out, “A Costly Regulation with No Benefits.” That sounds more like No on 37 campaign literature than a university study. But wait. This calls for scrolling back to the title page, where it is revealed that “the work for this project was undertaken with partial funding support from No on 37.”

View the original article here: UC Davis professors warn of high cost of Prop 37

Could internet addiction be genetic?

Not only is Internet addiction a legitimate compulsion, it may have the same genetic component as nicotine addiction, a new study suggests.

Out of nearly 850 people interviewed about their Internet habits, German researchers evaluated 132 who showed signs of being hooked to the Web, while another 132 without problematic Internet behavior were selected as a control group.

The addicted users said that all their thoughts revolved around the Internet during the day, and they felt that their well-being was harmed if they couldn’t go online. The participants’ average age was 25.

View the original article here: Could internet addiction be genetic?

Will Prop 37 cost California agriculture $1.2 billion?

Proposition 37 would result in $1.2 billion in higher costs for farmers and food processors, higher prices for consumers and a crush of costly regulations with no benefits, according to a new study by two University of California, Davis, agricultural economics professors.

“The proposed regulations have no basis in science and impose rules that would have significant costs for food producers, processors and marketers, and ultimately for consumers, while providing misinformation and no demonstrable benefits,” University of California, Davis, Agricultural and Resource Economics professors Julian Alston and Daniel Sumner conclude in a study released today.

Proposition 37 is a food labeling measure that would ban the sale of tens of thousands of safe, common grocery products only in California unless they are specially repackaged, relabeled or made with higher cost ingredients. This new, 48-page report from researchers at one of the world’s top agricultural universities conclusively reveals that Proposition 37 threatens California’s economy and ability to compete with other states, and would impose costs directly on shoppers, farmers, manufacturers, seed companies, grocers and workers.

View the original article here: Will Prop 37 cost California agriculture $1.2 billion?

Are GMO labels a scarlet letter?

Proposition 37 could make California the first state in the country to require labels on foods made with genetically-modified ingredients. It’s shaping up to be one of the most contentious — and certainly the most expensive — battles on the state’s November ballot.

On one side are organic food groups that have spent about $3 million in support of the labeling law. On the other are biotech firms like Monsanto, and food giants like Pepsi, Sara Lee, and General Mills, which have contributed upwards of $28 million to try and keep GMO labels off food packages.

View the original article here: Are GMO labels a scarlet letter?